Nguyen Lam-Phuong, Ahdoot Stella, Sriratanaviriyakul Narin, Zhang Yanhong, Stollenwerk Nicholas, Schivo Michael, Harper Richart
University of California, Davis, CA, USA; VA Northern California Health Care System, Mather, CA, USA.
University of California, Davis, CA, USA.
J Investig Med High Impact Case Rep. 2016 Apr 13;4(2):2324709616643990. doi: 10.1177/2324709616643990. eCollection 2016 Apr-Jun.
Acute fibrinous and organizing pneumonia (AFOP) is an extremely rare, relatively new, and distinct histological pattern of acute lung injury characterized predominately by the presence of intra-alveolar fibrin and associated organizing pneumonia. AFOP may be idiopathic or associated with a wide spectrum of clinical conditions. It has a variable clinical presentation from mild respiratory symptoms to that similar to the acute respiratory distress syndrome. Currently there is no consensus on treatment, and corticosteroids previously were of unclear benefit. To date, there are less than 40 cases of AFOP reported in the literature and only one has been linked to hematopoietic stem cell transplantation. Here we report the first case series of 2 patients who developed AFOP following allogenic stem cell transplant that were successfully treated with high-dose corticosteroids.
急性纤维素性机化性肺炎(AFOP)是一种极其罕见、相对较新且独特的急性肺损伤组织学类型,主要特征为肺泡内纤维蛋白的存在及相关的机化性肺炎。AFOP可能是特发性的,也可能与多种临床情况相关。其临床表现多样,从轻微呼吸道症状到类似急性呼吸窘迫综合征的症状。目前对于治疗尚无共识,且此前使用皮质类固醇的益处尚不明确。迄今为止,文献报道的AFOP病例不足40例,仅有1例与造血干细胞移植相关。在此,我们报告首例2例同种异体干细胞移植后发生AFOP的病例系列,这2例患者经大剂量皮质类固醇成功治疗。